All In Biotech

Drug Trial Radar · NCT04055818

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

Proof-of-concept Study of Nicotinamide and Oral Tetrahydrouridine (THU) and Decitabine to Treat High Risk Sickle Cell Disease

Last checked: Nov 20, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Jan 24, 2020

Primary completion

Oct 30, 2028

Study completion Jan 20, 2029

Sponsor

Lead sponsor
EpiDestiny, Inc.Industry
Sponsor type
Industry
Collaborators
National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
First posted
Aug 14, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A randomized control trial in 20 subjects with sickle cell disease comparing oral THU-decitabine to nicotinamide and in combination (THU, decitabine and nicotinamide).

Conditions

  • Sickle Cell Disease

Interventions

  • NicotinamideDrug

    Oral nicotinamide (Vitamin B3) alone compared to THU Decitabine combination

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Blood HemoglobinTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Illinois at Chicago College of Medicine

    Chicago, Illinois · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.